Pluripotent Stem Cells: Current Understanding and Future Directions—2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 1701
Special Issue Editor
Interests: induced pluripotent stem cells; mesenchymal stem cells; transplant immunology; autoimmunity; peripheral nerve regeneration; vascularized composite allotransplantation; cell therapy; exosome therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue, “Pluripotent Stem Cells: Current Understanding and Future Directions—2nd Edition”, will focus on induced pluripotent stem cells (iPSCs) and potential therapeutic applications for their derivatives.
Induced pluripotent stem cells can be generated by reprogramming somatic cells using the delivery of exogenous pluripotent factors such as Oct4, Sox2, Nanog, and Klf4. The delivery methods for pluripotent transgenes include genomic integrated strategies, such as lentivirus or retrovirus transduction, and non-genomic integrated strategies, such as episomal plasmid transfection, adenovirus transduction, mRNA transfection, or Sendai virus transduction. The overexpression of these pluripotent factors makes somatic cells undergo transformation into pluripotent stem cells through the obtainment of a round morphology, multilineage differentiation abilities, and self-renewal properties. Therefore, iPSCs are similar to embryonic stem cells (ESCs) in that they possess similar regenerative abilities and can differentiate into any cell type in the body, whereas iPSC generation does not face the ethical controversies related to ESC sources. The therapeutic applications of autologous iPSCs hold great promise in tissue engineering and regenerative and personalized medicine. iPSC-differentiated cells may have the potential to be applied to disease cures or the screening of new drugs. Moreover, allogeneic iPSC-derived exosomes (iPSCs-Exos) act as a form of cell-free therapy and may have broad application prospects in disease treatments.
We invite authors in this field to submit original research or review articles related to the important and rapidly progressing field of iPSC-associated medicine.
Dr. Aline Yen Ling Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- induced pluripotent stem cells
- iPSC generation
- somatic reprogramming
- iPSC-derived cells
- cell therapy
- exosome therapy
- therapeutic application
- drug screening
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
